Ceftizoxime-induced immune hemolytic anemia associated with multi-organ failure / 영남의대학술지
Yeungnam University Journal of Medicine
;
: 123-127, 2017.
Article
in Korean
| WPRIM
| ID: wpr-84525
ABSTRACT
Drug-induced immune hemolytic anemia (DIIHA) is a rare side effect of drugs. DIIHA may cause a systemic inflammatory response that results in acute multi-organ failure and death. Ceftizoxime belongs to the class of third generation cephalosporins, which are the most common drugs associated with DIIHA. Herein, we present a case of a 66-year-old man who developed fatal DIIHA after receiving a second dose of ceftizoxime. He was admitted to receive photodynamic therapy. He had a history of a single parenteral dose of ceftizoxime 3 months prior to admission. On the day of the procedure — shortly after the infusion of ceftizoxime — the patient's mental status was altered. The blood test results revealed hemolysis. Oliguric acute kidney injury developed, and continuous renal replacement therapy had to be applied. On the suspicion of DIIHA, the patient underwent plasmapheresis. Diagnosis was confirmed by a detection of drug-dependent antibody with immune complex formation. Although his hemolysis improved, his liver failure did not improve. He was eventually discharged to palliative care, and subsequently died.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Palliative Care
/
Photochemotherapy
/
Ceftizoxime
/
Cephalosporins
/
Plasmapheresis
/
Liver Failure
/
Renal Replacement Therapy
/
Diagnosis
/
Acute Kidney Injury
/
Hematologic Tests
Type of study:
Diagnostic study
Limits:
Aged
/
Humans
Language:
Korean
Journal:
Yeungnam University Journal of Medicine
Year:
2017
Type:
Article
Similar
MEDLINE
...
LILACS
LIS